NCT01359111

Performance and Safety Evaluation of an Intradermal Delivery Device

Phase I Performance and Safety Evaluation of an Intradermal Delivery Device

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: PATH · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate whether an investigational vaccine delivery device (the ID adapter) can safely and precisely inject liquid into the intradermal layer of the skin.

Conditions

• Injections, Intradermal

Interventions

Type	Name	Description
DEVICE	PATH ID Adapter	Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin.

Timeline

• Start date: 2011-05-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2011-05-24
• Last updated: 2012-05-18
• Results posted: 2012-05-11

Locations

1 site across 1 country: United States